Healthcare Equipment and Supplies
Company Overview of Conceptus, Inc.
Conceptus, Inc. designs, develops, and markets minimally invasive devices for reproductive medical applications primarily in the United States, France, and Europe. It primarily provides Essure system, a permanent birth control system that delivers an insert into a woman’s fallopian tubes. The company sells its products through direct sales force and distribution networks to physicians and hospitals. Conceptus, Inc. was founded in 1992 and is headquartered in Mountain View, California. As of June 5, 2013, Conceptus, Inc. operates as a subsidiary of Bayer HealthCare, LLC.
331 East Evelyn Avenue
Mountain View, CA 94041
Founded in 1992
Key Executives for Conceptus, Inc.
Executive Vice President of Operations
Chief Compliance Officer, Executive Vice President, General Counsel and Secretary
Executive Vice President of Research and Development
Executive Vice President of Human Resources
Vice President of Strategic & Professional Marketing
Compensation as of Fiscal Year 2014.
Conceptus, Inc. Key Developments
Conceptus, Inc. Announces Board Resignations
Jun 5 13
On April 28, 2013, Conceptus, Inc. entered into an agreement and plan of merger with Bayer HealthCare LLC and Evelyn Acquisition Company. In accordance with the merger agreement, each of Kathryn A. Tunstall, D. Keith Grossman, Thomas F. Bonadio and Robert V. Toni resigned from the board of directors of the company and from all committees of the board on which such directors served, effective as of the acceptance time on June 5, 2013, subject to payment for the shares tendered into the offer.
Conceptus, Inc.(NasdaqGM:CPTS) dropped from NASDAQ Composite Index
Jun 5 13
Conceptus, Inc. will be removed from NASDAQ Composite Index.
Levi & Korsinsky, LLP Notifies Investors of Claims of Breaches of Fiduciary Duty and Other Violations of State Law Against the Board of Conceptus, Inc
May 6 13
Levi & Korsinsky notifies investors of Conceptus, Inc. of claims of breaches of fiduciary duty and other violations of state law against the board of directors of the company in connection with the sale of the company to Bayer HealthCare LLC. A complaint was filed in California state court. Under the terms of the transaction, Conceptus shareholders will receive $31.00 for each share of Conceptus stock they own. The claims concern whether the Conceptus Board of Directors breached their fiduciary duties to stockholders by failing to adequately shop the company before agreeing to enter into the transaction, and whether Bayer HealthCare LLC is underpaying for Conceptus stock, thus unlawfully harming Conceptus stockholders.
Similar Private Companies By Industry
Recent Private Companies Transactions
|No transactions available in the past 12 months.|